EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Clinical trials for EXUDATIVE AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smartphone app help wet AMD patients see better longer?
Disease control Not yet recruitingThis study looks at whether a home monitoring app can help people with wet age-related macular degeneration (eAMD) feel confident with longer gaps between eye injections. About 80 adults already receiving Aflibercept 8 mg will use the app and have regular eye exams for up to two …
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New hope for wet AMD patients: higher-dose drug may cut injection frequency
Disease control Not yet recruitingThis study looks at 100 adults with wet age-related macular degeneration who switched to a higher dose (8 mg) of the drug aflibercept. The goal is to see if this new dose allows them to go longer between eye injections while still controlling the disease. Researchers will compare…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
AI eye doctor: QiLin system aims to sharpen injection decisions
Knowledge-focused Not yet recruitingThis study tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. About 200 patients who have completed in…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:29 UTC